Dr. Joseph Goldstein

For the second summer, DART will be sponsoring four undergraduate science students to work in research laboratories studying Niemann-Pick type C disease.  Each of the labs is involved on the front lines of developing therapies for NP-C and two are working on obtaining approval from the U.S. Food and Drug Administration for a new drug …